Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.
Patent
1987-09-15
1991-08-13
Moskowitz, Margaret
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Hormones, e.g., prolactin, thymosin, growth factors, etc.
530350, 530351, 530380, 530395, 530413, 530414, 530415, 530416, 530417, C07K 1506, C07K 328
Patent
active
050397940
ABSTRACT:
A novel cell scattering factor, i.e., tumor egress factor (hereinafter "egressin") isolated from a clone derived from a human metastatic melanoma (M3827) which possesses a loose colony morphology and from a human monocytic cell line (U937) and processes for producing the same. Egressin is useful for the production of immunological reagents for the detection and treatment of metastatic lesions, for aiding in the transport of drugs across the blood-brain barrier, and for aiding in the control of the inflammatory response.
REFERENCES:
Alitalo et al., EMBO J., 6(5), 1213-18, (1987).
DeLarco et al., PNAS (U.S.A.), 82, 5015-19, (Aug. 1985).
Liotta et al., PNAS (U.S.A.), 83, 3302-6, (May 1986).
De Larco Joseph E.
Wier Marjorie L.
Kushan Jeff
Moskowitz Margaret
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
Tumor egress factor and processes for producing the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor egress factor and processes for producing the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor egress factor and processes for producing the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1528299